Research Article
Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study
Table 2
Metabolite ratios in the frontal and temporal lobes for patients with schizophrenia and bipolar disorder and controls (means ± SD).
| Metabolite ratios | Patients with schizophrenia
| Patients with bipolar disorder
| Controls
| value |
| Left frontal lobe | NAA/Cr | 1.75 ± 0.22 | 1.75 ± 0.32 | 1.74 ± 0.21 | NS | Glx/Cr | 1.98 ± 0.29 | 1.93 ± 0.56 | 2.17 ± 0.39 | NS | Cho/Cr | 0.99 ± 0.17 | 0.99 ± 0.12 | 0.90 ± 0.17 | NS | mI/Cr | 0.76 ± 0.26 | 0.78 ± 0.19 | 0.71 ± 0.25 | NS | NAA/H2O | 0.47 ± 0.08 | 0.47 ± 0.08 | 0.46 ± 0.06 | NS | Glx/H2O | 0.54 ± 0.08 | 0.50 ± 0.12 | 0.56 ± 0.10 | NS | Cho/H2O | 0.26 ± 0.04 | 0.27 ± 0.05 | 0.23 ± 0.04 | 0.04 | Cr/H2O | 0.27 ± 0.02 | 0.26 ± 0.05 | 0.26 ± 0.03 | NS | mI/H2O | 0.20 ± 0.07 | 0.21 ± 0.05 | 0.18 ± 0.06 | NS | Left temporal lobe | NAA/Cr | 1.83 ± 0.37 | 1.73 ± 0.36 | 1.78 ± 0.35 | NS | Glx/Cr | 2.24 ± 0.44 | 2.18 ± 0.58 | 2.24 ± 0.66 | NS | Cho/Cr | 0.98 ± 0.17 | 0.97 ± 0.20 | 1.00 ± 0.20 | NS | mI/Cr | 0.73 ± 0.22 | 0.73 ± 0.27 | 0.72 ± 0.24 | NS | NAA/H2O | 0.45 ± 0.11 | 0.39 ± 0.07 | 0.40 ± 0.08 | NS | Glx/H2O | 0.62 ± 0.07 | 0.53 ± 0.14 | 0.54 ± 0.15 | 0.02 | Cho/H2O | 0.25 ± 0.06 | 0.23 ± 0.07 | 0.23 ± 0.06 | NS | Cr/H2O | 0.25 ± 0.06 | 0.24 ± 0.04 | 0.23 ± 0.05 | NS | mI/H2O | 0.18 ± 0.06 | 0.17 ± 0.06 | 0.17 ± 0.07 | NS |
|
|
Kruskal-Wallis test. NS: nonsignificant; NAA: N-acetylaspartate; Glx: GABA, glutamine, and glutamate; Cho: choline-containing compounds; Cr: creatine plus phosphocreatine; mI: myo-inositol.
|